1-[5-chloro-6-(trifluoromethoxy)-1H-1,3-benzodiazol-2-yl]-1H-pyrazole-4-carboxylic acid, 5mg

2-Amino-3-nitro-5-fluoropyridine, 98.0%, 1g

Acid Black 1>95.0%(HPLC)500g

N-Hidroxisuccinimida, mínimo 99 %, para síntesis, 500 g, envase de vidrio

2-Bromo-1-fluoro-4-(methoxymethyl) benzene, 90.0%, 25g

4,6-Dichloro-5-methoxy-2-(methylthio)pyrimidine, 98%, 100mg

1,3-Bis(3-methacryloxypropyl)tetramethyldisiloxane, 90%, 10g

2-methyl-1-(naphthalene-2-carbonyl)piperazine, 95.0%, 1g

2,2-Bis(3-(3-aminobenzoylamino)-4-hydroxyphenyl)hexafluoropropane>97.0%(HPLC)(qNMR)1g

4-Bromo-3-methoxybenzene-1,2-diamine, 97%, 100mg

Monohidrato de clorhidrato de D-cisteína, mínimo 98%, para bioquímica, 5 g, envase de plástico.

4-CHLOROTHIAZOLO[4,5-C]PYRIDINE, 97.0%, 100mg

2,2-Difluoroethanol, 99.0%, 25g